Mesenchymal Stem Cell Therapy Ameliorates Diabetic Hepatocyte Damage in Mice by Inhibiting Infiltration of Bone Marrow–Derived Cells

Abstract

MSC therapy is a powerful tool for repairing diabetic hepatocyte damage by inhibiting inflammatory reactions induced by BMDCs and IR. These effects are likely the result of humoral factors derived from MSCs.